Haakon Overli

Venture Capital, Angel/Individual, Investment Partner · United Kingdom

Haakon Overli is a venture capital investor and angel investor based in the United Kingdom. They invest in Life Science, Market Research, FinTech and UK-based Startups, typically at the Series B and Series A stage. Their portfolio includes Bathrooms.com, Bityota, Minute Media and Miinto and 7 other companies.

Investment stages

Industries

Portfolio companies (11)

Similar investors in Life Science

  • Eyal RabinovichVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareCommercialTelecommunicationsData Science

    Portfolio: PharmEasy, Shadowfax

    Contact details available

  • Richard LeaverVerified

    Venture Capital, Investor · United Kingdom

    SeedHealth CareWearablesCybersecuritySports

    Portfolio: Purepotions Skincare, Starbon Technologies

    Contact details available

  • Steve Adkin

    Venture Capital · United Kingdom

    Health CareHospitalsLife ScienceSoftware

    Portfolio: Convergence Pharmaceuticals, Ulthera

    Contact details available

  • Hannah ParkerVerified

    Venture Capital, Private Equity Firm, Investment Partner · United Kingdom

    SeedE-commerceEnterprise SoftwareHR TechCryptocurrency

    Contact details available

  • Fatima Kranc, DPhil

    Angel/Individual · United Kingdom

    Health CareCommercialTelecommunicationsCybersecurity

    Portfolio: Nu Quantum, Colorifix

    Contact details available

  • Melya Hughes Crameri

    Venture Capital, Angel/Individual, Investor · United Kingdom

    SeedLife ScienceBiotechnology

    Portfolio: Evolva

    Contact details available

  • Alan Barge

    Venture Capital, Private Equity Firm, Micro VC · United Kingdom

    Health CareE-commerceLife ScienceAutomotive

    Portfolio: import.io, Virtual Arts Ltd.

    Contact details available

  • Alston ZechaVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    SeedHealth CareCommercialTelecommunicationsData Science

    Portfolio: PharmEasy, Shadowfax

    Contact details available